Pieris Pharmaceuticals, Inc. (PIRS): Price and Financial Metrics
PIRS Price/Volume Stats
| Current price | $17.30 | 52-week high | $23.20 |
| Prev. close | $17.25 | 52-week low | $6.20 |
| Day low | $17.10 | Volume | 4,600 |
| Day high | $17.47 | Avg. volume | 47,395 |
| 50-day MA | $16.92 | Dividend yield | N/A |
| 200-day MA | $13.64 | Market Cap | 22.84M |
PIRS Stock Price Chart Interactive Chart >
Pieris Pharmaceuticals, Inc. (PIRS) Company Bio
Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops Anticalin-based drugs. The company develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. The company is based in Boston, Massachusetts.
PIRS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Continue Researching PIRS
Want to see what other sources are saying about Pieris Pharmaceuticals Inc's financials and stock price? Try the links below:Pieris Pharmaceuticals Inc (PIRS) Stock Price | Nasdaq
Pieris Pharmaceuticals Inc (PIRS) Stock Quote, History and News - Yahoo Finance
Pieris Pharmaceuticals Inc (PIRS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...